**Core Concept**
The question is related to the expression of certain markers in **poorly differentiated carcinomas**, which are a type of cancer that lacks clear cellular differentiation. This concept is rooted in **oncology** and **histopathology**, where the identification of specific markers helps in diagnosing and classifying tumors.

**Why the Correct Answer is Right**
Although the specific correct answer is not provided, poorly differentiated carcinomas often express markers related to their origin or lineage. For example, **cytokeratins** are expressed in epithelial-derived tumors, while **vimentin** is expressed in mesenchymal-derived tumors. The expression of these markers is crucial for the diagnosis and classification of tumors.

**Why Each Wrong Option is Incorrect**
**Option A:** Without the specific details of the options, it's challenging to provide a precise explanation. However, in general, incorrect options might include markers that are not typically associated with poorly differentiated carcinomas.
**Option B:** Similarly, this option might be incorrect if it represents a marker that is not commonly expressed in these types of tumors.
**Option C:** This option could be incorrect if it corresponds to a marker that is more specific to well-differentiated tumors or a different type of cancer altogether.
**Option D:** Without knowing the specifics, this option might be incorrect if it does not align with the typical markers expressed by poorly differentiated carcinomas.

**Clinical Pearl / High-Yield Fact**
A key point to remember is that **immunohistochemistry** plays a critical role in the diagnosis of poorly differentiated carcinomas, as it helps identify the tumor's origin and guide treatment decisions. Recognizing the expression patterns of various markers is essential for accurate diagnosis.

**Correct Answer:** Correct Answer: D. p63